An anti-GDF15 monoclonal antibody, ponsegromab, was recently shown to ameliorate cachexia caused by nonsmall cell lung cancer and pancreatic cancer62, and CLIA-certified assays exist for measuring PTHrP and GDF15 in plasma. Here, GDF15 is linked to lung cancer.